baber/WOPTO huggingface dataset:
Patent AU-677907-B2 (AU)
Title: A topical dressing, method of manufacturing a topical dressing and use of a topical dressing
Inventor: NYQVIST-MAYER ADELA
IPC: A61M35/00
Filed: 1995-04-05
Granted: 1997-05-08
Abstract: PCT No. PCT/SE95/00368 Sec. 371 Date Aug. 22, 1996 Sec. 102(e) Date Aug. 22, 1996 PCT Filed Apr. 5, 1995 PCT Pub. No. WO95/26778 PCT Pub. Date Oct. 12, 1995A topical dressing for dermal or transdermal administration of a substance, comprising a backing structure comprising a disc, a pad containing the active substance, a resilient layer with an adhesive provided on one side thereof, the resilient layer and the adhesive being provided with a cut-out defining a cavity in which the pad is placed, the disc of the backing structure being provided on the side of the resilient layer remote from the side provided with the adhesive and partly covering the resilient layer, and a covering structure having a release layer and a dish, the dish being formed to receive the pad during production and storage of the dressing, said covering structure being provided on the adhesive side of the resilient layer, whereby the backing structure is provided with one or more strips extending outwardly from the periphery edge of the backing disc towards the periphery edges of the resilient layer and in that the cover structure and the backing structure are sealed together within the cavity. There is also provided a method of producing a topical dressing according to the invention.
Patent AU-566207-B2 (AU)
Title: Anchor band and reel
Inventor: HALLBERG HAKAN
IPC: B63B21/22
Filed: 1984-01-27
Granted: 1987-10-15
Abstract: The invention relates to a device for anchors, especially in sailing and motor boats, and it includes a flexible band (1) which is comparatively thin in relation to its width, is fixable to the anchor at one end and connected at the other end to a band magazine (2) which comprises a reel built up of two ridgidly interconnected end wall plates (3, 4) which are non-rotatably attachable to a convenient part of the boat and spaced from one another at a distance adapted to the band width, and a sleeve (5) which is mounted centrally on the end wall plates, is rotatable by means of a crank orthe like and is provided with an attachment for the band end.
Patent AU-547258-B2 (AU)
Title: Terminal set circuit
Inventor: RITZ HERMANN
IPC: H04M1/58
Filed: 1984-03-16
Granted: 1985-10-10
Abstract: 1. A hybrid circuit for a subscriber station, centrally fed via the a/b-wire of a telecommunications system, in particular a telephone system, comprising a microphone, a receiver and a balancing dummy line, characterized in that a first resistor (R1 ) and a capacitive receiver (F) are connected in series between the a/b-wires, that a microphone (M) and a transistor choke (TD) are connected in parallel therewith, the junction point between the first resistor (R1 ) and the receiver (F) and the junction point between the microphone (M) and the transistor choke being connected to one another by a further resistor (R2 ) and that a balancing dummy line network is connected parallel to the transistor choke.
Patent AU-603323-B2 (AU)
Title: Body fluid sample collection tube assembly
Inventor: DUFRESNE CHRISTOPHER M
IPC: B01L3/14
Filed: 1989-02-03
Granted: 1990-11-08
Abstract: An assembly (10) is provided for receiving, maintaining and storing blood samples taken from individuals some of whom may have a disease which can contaminate anyone handling the sample. The assembly (10) includes a glass tube (14) which may be evacuated for facilitating and receiving a blood sample coaxially retained within a plastic tube (12) which retains the sample and the general integrity of the assembly (10) in the event that the glass tube (14) cracks or breaks during handling. Thus, the glass tube (14) maintains a long shelf-life for the evacuated tube, and does not react adversely or interfere with blood chemistries, while the outer plastic sleeve (12) protects the user from broken glass and/or contamination. A special interlock ring (18) holds the glass tube (14) coaxially in place relative to the plastic tube (12).
Patent AU-752260-B2 (AU)
Title: Strap-attached spur
Inventor: BALKENHOL KLAUS
IPC: A43C17/00
Filed: 1999-02-18
Granted: 2002-09-12
Abstract: The invention relates to a strap-attached spur which is configured substantially U-shaped and has two lateral bars. Two spur strap eyelets are provided for in each free end of each bar and receive a spur strap of the strap attachment. The two spur strap eyelets of either end are not parallel but form an acute angle between each other.
Patent AU-570083-B2 (AU)
Title: Instant coffee aromatization
Inventor: GHODSIZADEH YOUSEF
IPC: A23F5/36
Filed: 1984-11-20
Granted: 1988-03-03
Abstract: A process for aromatizing instant coffee by transferring volatile aromatics from a roast and ground coffee to the instant coffee comprises heating roast and ground coffee to a temperature of about 30 DEG  to 95 DEG C and allowing volatile aromatics released during heating to come into contact with the instant coffee which is maintained at a temperature of about 0 DEG  to 35 DEG C. The aromatized instant coffee has improved in-jar aroma.
Patent AU-635214-B2 (AU)
Title: Static fluid flow mixing apparatus
IPC: B01F5/06
Filed: 1989-07-27
Granted: 1993-03-18
Abstract: A static mixing device adapted to be inserted in a fluid stream having a main flow direction with respect to a closed conduit, comprises at least two tabs inclined in the flow direction at a preselected elevation angle between 10 DEG  and 45 DEG  to the surface of the conduit. The tabs are spaced apart in a direction transverse to the flow direction, the length and width of the tabs being selected so as to generate pairs of oppositely rotating predominantly streamwise vortices at the tips of each tab, and downstream hairpin vortices interconnecting adjacent streamwise vortices generated by a single tab.
Patent AU-748303-B2 (AU)
Title: Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells
Inventor: PAVESIO ALESSANDRA
IPC: D04H1/4266
Filed: 1999-05-25
Granted: 2002-05-30
Abstract: Biomaterials are disclosed comprised of biodegradable, biocompatible, and bioabsorbable non-woven fabric materials for use in surgery for the guided regeneration of tissues. The non-woven fabric materials are comprised of threads embedded in a matrix, wherein both the matrix and the threads can be comprised of esters of hyaluronic acid, used singly or in combination, or esters of hyaluronic acid in combination with esters of alginic acid or other polymers.
Patent AU-675954-B2 (AU)
Title: Biodegradable polymeric composition
Inventor: BASTIOLI CATIA
IPC: C08L3/00
Filed: 1993-06-14
Granted: 1997-02-27
Abstract: PCT No. PCT/EP93/01530 Sec. 371 Date Mar. 27, 1995 Sec. 102(e) Date Mar. 27, 1995 PCT Filed Jun. 14, 1993 PCT Pub. No. WO94/03543 PCT Pub. Date Feb. 17, 1994A polymeric composition comprises a matrix including a starch component and at least one synthetic thermoplastics polymeric component in which a filler is dispersed, characterised in that the matrix includes a fluidising agent selected from the group consisting of C12-C22 fatty acids, C12-C22 fatty alcohols, esters and amides of the said fatty acids, poly and polyglycol ethers of alditols or polyglycerols esterified with the said fatty acids and their mixtures and the said filler comprises natural fillers of an organic nature dispersed in the matrix in quantities of from 5% to 70% by weight with reference to the total weight of the composition.
Patent AU-763609-B2 (AU)
Title: Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix
Inventor: REIN HUBERT
IPC: A61K9/20
Filed: 2000-04-20
Granted: 2003-07-31
Abstract: In the preparation of a medicament dosage form (or its precursor) by extrusion, the dosage form comprises a matrix having properties determined by the extrusion process. The matrix contains (a) at least one active agent, (b) one or more polysaccharides (and their derivatives and complexes) and, optionally, (c) one or more saccharides (and their derivatives) and (d) other materials. An independent claim is included for the dosage forms as described above.
Patent AU-710181-B2 (AU)
Title: Vaccines for plague
Inventor: TITBALL RICHARD WILLIAM
IPC: A61K39/07
Filed: 1996-03-13
Granted: 1999-09-16
Abstract: PCT No. PCT/GB96/00571 Sec. 371 Date Sep. 15, 1997 Sec. 102(e) Date Sep. 15, 1997 PCT Filed Mar. 13, 1996 PCT Pub. No. WO96/28551 PCT Pub. Date Sep. 19, 1996A method of protecting a human or animal body from the effects of infection with Y. pestis is provided comprising administering to the body a vaccine including Yersinia pestis V antigen and Yersinia pestis F1 antigens or a protective epitopic part of each of these in a form other than whole Y. Pestis organisms. Preferably the antigens are administered in the form of a live vaccine or as recombinantly produced isolated and/or purified proteins. DNA encoding the whole or part of the F1 antigen and DNA encoding the whole or part of the V antigen may be used directly as a agnetic vaccine.
Patent AU-634208-B2 (AU)
Title: Process for the disposal of water-soluble or colloidal-form trash impurities in paper-manufacturing pulp
IPC: D21H17/37
Filed: 1990-02-16
Granted: 1993-02-18
Abstract: The invention relates to a process for fixing foreign substances in papermaking, wherein the agents used for fixing the foreign substances are polymers, consisting of cationic groups, of 50 to 100% by weight of quaternised dimethylaminopropylacrylamide or dimethylaminopropylmethacrylamide and 0 to 50% by weight of acrylamide, acrylic acid, methacrylic acid or acrylamidomethylpropanesulphonic acid, which have an intrinsic viscosity of less than 150 ml/g. The fixing agent is added to the pulp run and/or to the circulating water in quantities of up to 1% by weight relative to the dry weight of the paper produced.
Patent AU-760249-B2 (AU)
Title: Novel c-2 s/o- and s/n formaldehyde acetal derivatives of carbapenem-3-carboxylic acids and their use as antibiotics and beta-lactamase inhibitors
Inventor: PFAENDLER HANS RUDOLF
IPC: A61P31/04
Filed: 1999-07-23
Granted: 2003-05-08
Abstract: The compounds of the general formula I <CHEM> wherein R<1> denotes hydrogen, hydroxymethyl or 1-hydroxyethyl, R<2> denotes hydrogen or methyl and R<3> denotes a pharmaceutically acceptable group which is bonded to the remaining part of the molecule by an oxygen-carbon single bond or a nitrogen-carbon single bond, and their pharmaceutically acceptable salts, esters and amide derivatives are broad spectrum antibiotics and ss-lactamase inhibitors.
Patent AU-718955-B2 (AU)
Title: Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
Inventor: ISH-HOROWICZ DAVID
IPC: C07K14/435
Filed: 1996-03-07
Granted: 2000-05-04
Abstract: The present invention relates to nucleotide sequences of Serrate genes, and amino acid sequences of their encoded proteins, as well as derivatives (e.g., fragments) and analogs thereof. In a specific embodiment, the Serrate protein is a human protein. The invention further relates to fragments (and derivatives and analogs thereof) of Serrate which comprise one or more domains of the Serrate protein, including but not limited to the intracellular domain, extracellular domain, DSL domain, cysteine rich domain, transmembrane region, membrane-associated region, or one or more EGF-like repeats of a Serrate protein, or any combination of the foregoing. Antibodies to Serrate, its derivatives and analogs, are additionally provided. Methods of production of the Serrate proteins, derivatives and analogs, e.g., by recombinant means, are also provided. Therapeutic and diagnostic methods and pharmaceutical compositions are provided. In specific examples, isolated Serrate genes, from Drosophila, chick, mouse, Xenopus and human, are provided.
Patent AU-705431-B2 (AU)
Title: Indanylpiperidines as melatonergic agents
Inventor: MATTSON RONALD J
IPC: C07D409/06
Filed: 1996-05-31
Granted: 1999-05-20
Abstract: Certain indanyl piperidines of formula (I) are useful as melatonergic agents and can treat various CNS disorders. They are useful in treating sleep disorders and other conditions related to circadian rhythms <CHEM>  wherein:   R   is H, C1-7 alkoxy, halogen, hydroxyl, C1-4 haloalkoxy or C1-4 alkoxyphenyl C1-7 alkoxy; Y   is hydrogen or halogen; Z   is O or S; m   is 1 or 2; and R<1>   is hydrogen, C1-6 alkyl (straight or branched), C1-6 haloalkyl (straight or branched), C2-8 alkylthioalkyl, C2-8 alkyloxyalkyl, C2-6 alkenyl (straight or branched), C3-5 cycloalkyl, C3-5 cycloalkenyl, thienyl, furanyl, thiadiazolyl, pyrrolyl, C1-6 alkylthio or NR<2>R<3>, in which R<2> and R<3> are independently hydrogen or C1-4 alkyl.
Patent AU-720756-B2 (AU)
Title: Apparatus for producing multi-part printed products
Inventor: JAEGER ERICH
IPC: B65H39/075
Filed: 1998-01-20
Granted: 2000-06-08
Abstract: An apparatus for producing multi-part printed products comprising an upwardly open V-shaped continuous conveying channel (1), and a V-shaped processing channel (2) arranged above the conveying channel (1). A plurality of supply locations (11-17) are arranged serially along the processing route for supplying the printed product parts (A-G). The processing channel (2) has individual successive processing regions (3-10) which receive the product parts supplied at the supply locations and between which through-passages (18, 19, 119, 20, 120) are provided which open toward the bottom and by means of which the product parts (A-G) pass out of the processing region and into the underlying conveying channel (1).
Patent AU-650234-B2 (AU)
Title: Polymerization process and catalyst
Inventor: JOB ROBERT C
IPC: C08F4/654
Filed: 1990-04-19
Granted: 1994-06-16
Abstract: A process and a catalyst for the production of elastomeric primarily syndiotactic polypropylene characterized by short average block lengths wherein propylene is polymerized in the presence of the catalyst which comprises the reaction product of a magnesium alkoxide and a tetravalent titanium halide which takes place in the presence of an electron donor, an organoaluminum compound, and a selectivity control agent which is an effectively hindered heterocyclic aromatic nitrogen compound wherein the hindrance is not provided by a Cl- or methoxy group.
Patent AU-636358-B2 (AU)
Title: Novel propargyl compounds, and uses and processes of preparation thereof
IPC: C08K5/35
Filed: 1990-06-20
Granted: 1993-04-29
Abstract: Compounds of the formula <CHEM>  wherein  Y and Z are each independently O, S, or N-R;  X is H, Br or I; A and R is H, Br or I; are each independently one of; (C1 to C18) straight or branched alkyl; (C3 to C8) cycloalkyl; (C3 to C6) alkenyl; (C3 to C6) alkynyl except propargyl; (C7 to C12) aralkyl; (C6 to C12) aryl optionally substituted with one or more halogen, (C1 to C4) alkyl or haloalkyl, (C1 to C4) alkoxy, nitro, cyano, carboxyl (C1 to C4) alkoxycarbonyl, (C1 to C4) alkyl thio, -S(O)nR<2> where n is 1 or 2 and R2 is (C1-C4) alkyl; a 2-thienyl, 3-thienyl, 2-furyl, 3-furyl, 2-pyridyl, 3-pyridyl, or 4-pyridyl moiety each optionally substituted with halo or nitro; or H, with the proviso that R is H only when X is I or Br. are diclosed as useful microbicides and herbicides.
Patent AU-782555-B2 (AU)
Title: Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
Inventor: ASTATKE MEKBIB
IPC: C12Q1/68
Filed: 2000-06-30
Granted: 2005-08-11
Abstract: The present invention relates to nucleic acid inhibitors, compositions and method for enhancing synthesis of nucleic acid molecules. In a preferred aspect, the invention relates to inhibition or control of nucleic acid synthesis, sequencing or amplification. Specifically, the present invention discloses nucleic acids having affinity for polypeptides with polymerase activity for use in such synthesis, amplification or sequencing reactions. The nucleic acid inhibitors are capable of inhibiting nonspecific nucleic acid synthesis under certain conditions (e.g., at ambient temperatures). Thus, in a preferred aspect, the invention relates to "hot start" synthesis of nucleic acid molecules. Accordingly, the invention prevents, reduces or substantially reduces nonspecific nucleic acid synthesis. The invention also relates to kits for synthesizing, amplifying, reverse transcribing or sequencing nucleic acid molecules comprising one or more of the nucleic acid inhibitors or compositions of the invention. The invention also relates to using the inhibitors of the invention to prevent viral replication or treat viral infections in a subject. Thus, the invention relates to therapeutic methods and pharmaceutical compositions using the inhibitors of the invention. The invention thus may be used for    in vivo     and    in vitro     inhibition of nucleic acid synthesis and /or inhibition of polymerase acitivity.
Patent AU-694933-B2 (AU)
Title: Chimeric L- and P-selectin by exchange of domains - uses thereof
Inventor: TEDDER THOMAS F
IPC: G01N33/564
Filed: 1994-01-25
Granted: 1998-08-06
Abstract: Chimeric peptides or polypeptides that combine ligand binding portions from within the lectin and EGF domains of two different selectins are disclosed. The peptides or polypeptides can be constructed solely of the indicated portions of lectin or EGF domains or they can include portions of any of the remaining domains (SCR, transmembrane or cytoplasmic), or the entire extracellular portion, of a generic selectin molecule. The peptides or polypeptides also can be joined to a carrier protein (e.g., a soluble portion of an immunoglobulin molecule) to increase the serum half-life of the therapeutic agent. The chimeric polypeptides can be used as therapeutic agents to antagonize selectin function. They are also useful for screening for agents that are simultaneously antagonists of the function of lectin and EGF domains of different selectins.
Patent AU-600443-B2 (AU)
Title: Hydrocarbyl-substituted succinic acid/anhydride/amine terminated poly (oxyalkylene)
Inventor: FORSBERG JOHN W
IPC: C08L63/00
Filed: 1986-07-25
Granted: 1990-08-16
Abstract: A composition is disclosed which comprises a water-dispersible reaction product of (A) at least one compound represented by the formula  <IMAGE>  wherein R is a hydrocarbyl group of from about 8 to about 40 carbon atoms, with (B) at least one water-dispersible amine terminated poly(oxyalkylene). Aqueous concentrates and water-based functional fluids comprising these compositions are also disclosed. These reaction products are useful as shear-stable thickeners for such functional fluids.
Patent AU-669433-B2 (AU)
Title: Methods and apparatus for use in forming recesses in cast bodies
Inventor: ELLIS-CALLOW TREVOR JAMES
IPC: B28B23/00
Filed: 1994-05-03
Granted: 1996-06-06
Abstract: The invention provides for methods and apparatus for use in connection with the casting of bodies, e.g. of concrete panels, which are to contain within them one or more anchor members (40) which extend towards the surface of the body and are accessible within recesses formed in said surface. The releasible attachment of a recess former (10) to an anchor (40) to form an assembly for use in the casting of a body in which body the anchor (40) is to be secured during casting and from which body the recess former (10) is to be removed after casting to leave a cast recess containing a portion of the anchor (40) is provided in which a connector member (26) is applied to the said portion of the anchor (40) to engage at least one formation (42) provided on said anchor (40), the connector member (26) and the said portion of the anchor (40) are placed into a cavity (20) in the recess former (10), and the connector member (26) is releasably secured in the cavity (20), the arrangement being such that the walls (24) of the cavity (20) bear on the connector member (26) to prevent the disengagement thereof from the said formations (42) on the anchor (40) whilst the connector member (26) is in the cavity (26) in the recess former (10). <IMAGE>
Patent AU-682029-B2 (AU)
Title: Prodrugs with enhanced penetration into cells
Inventor: KOZAK ALEXANDER
IPC: A61K47/48
Filed: 1994-03-30
Granted: 1997-09-18
Abstract: The invention relates to a pharmaceutically acceptable prodrug which is a covalent conjugate of a pharmacologically active compound and an intracellular transporting adjuvant, characterized by the presence of a covalent bond which is scission-sensitive to intracellular enzyme activity. The prodrug may be used in a technique for treating a condition or disease in a human related to supranormal intracellular enzyme (.e.g. phospholipase and/or esterase) activity, whereby on administering it to a human having such condition or disease, the bond is broken in response to such activity, and the pharmacologically active compound accumulates selectively within cells having such supranormal intracellular enzyme activity. Exemplary conjugates are esters of the carboxylic function in the formula, with e.g. heptanoyl-sn-3-glycerophosphoryl-choline or octanoyl-sn-3-glycerophosphoryl-choline.
Patent AU-593593-B2 (AU)
Title: Novel 4-benzyl-1-(2h)-phthalazinone derivatives
Inventor: ENGEL JURGEN
IPC: C07D451/04
Filed: 1986-11-10
Granted: 1990-02-15
Abstract: There are provided 4-benzyl-1-(2H)-phthalazinone derivatives having antiallergic activity of the formula    <IMAGE>  I  wherein R1 represents fluorine, chlorine, bromine, trifluoromethyl, C1-C6-alkyl, hydroxy, C1-C6-alkoxy, C2-C6-alkanoyloxy, amino, C1-C6-alkylamino, di-C1-C6-alkylamino, C2-C6-alkanoylamino, C2-C6-alkanoyl-C1-C6-alkylamino or a nitro group, R2 represents hydrogen or has one of the meanings given for R1, whereby R1 and R2 may be the same or different, the radicals R3 and R4 are the same or different and represent hydrogen, halogen, C1-C6-alkyl, hydroxy, C1-C6-alkoxy, benzyloxy or C2-C6-alkanoyloxy and A represents an azacycloalkanyl radical, the aza nitrogen of which contains a C1-C6-alkyl group which is substituted by various radicals, and processes for their manufacture.
Patent AU-736916-B2 (AU)
Title: Method for plasma-arc welding of metals
Inventor: APUNEVICH ALEXANDR IVANOVICH
IPC: H05H1/26
Filed: 1998-02-17
Granted: 2001-08-09
Abstract: In a method for plasma-arc welding of metals with a direct or indirect arc, used as a plasma-producing medium is the vapor of a water-containing fluid doped with an organic solvent appearing as oxygen-containing hydrocarbon compounds, in particular, alcohols, and vapors are generated immediately in the plasma-arc torch. <IMAGE>
Patent AU-548977-B2 (AU)
Title: Method for the preparation of deazapurine nucleosides
Inventor: KRENITSKY THOMAS ANTHONY
IPC: C07H19/04
Filed: 1981-04-22
Granted: 1986-01-09
Abstract: A method for the preparation of 4-substituted-1- beta -D-ribofuranosyl-1H-imidazo- [4,5-c)-pyridines by enzymatic ribosylation of the corresponding 4-substituted-1H-imidazo-[4,5-c]-pyridine is disclosed. In particular the preparation of 4-amino-1- beta -D-ribofuranosyl-1H-imidazo-[4,5-c]-pyridine (3-deazadenosine) is described.
Patent AU-697869-B2 (AU)
Title: Method for marking objects and objects being marked with such method
Inventor: GUSTAFSSON STIG
IPC: A23G4/00
Filed: 1996-08-20
Granted: 1998-10-22
Abstract: PCT No. PCT/SE96/01027 Sec. 371 Date May 11, 1998 Sec. 102(e) Date May 11, 1998 PCT Filed Aug. 20, 1996 PCT Pub. No. WO97/10162 PCT Pub. Date Mar. 20, 1997Method for marking an object where the object is placed in a package whereby a pattern in said package is caused to make a marking in said object. Objects being marked with the above method. The invention is especially useful for marking solid or semi-solid formulations of drugs, candy and food-stuff. Specifically the invention is useful to mark nicotine-containing chewing gums. Other solid or semi-solid objects can equally well be marked using the present invention.